High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
| Autor: | Holtzman, Noa G., Curtis, Lauren M., Salit, Rachel B., Shaffer, Brian C., Pirsl, Filip, Ostojic, Alen, Steinberg, Seth M., Schulz, Eduard, Wilder, Jennifer S., Hughes, Thomas E., Rose, Jeremy, Memon, Sarfraz, Korngold, Robert, Gea-Banacloche, Juan C., Fowler, Daniel H., Hakim, Frances T., Gress, Ronald E., Bishop, Michael R., Pavletic, Steven Z. |
|---|---|
| Zdroj: | In Blood Advances 27 August 2024 8(16):4294-4310 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|